Stabl-Im clinical trial supply milestone achieved

Summary by 6ix AI

TrivarX Limited has announced the securing of investigational product supply for its Stabl-Im clinical trial, marking a key development milestone. The trial is designed to provide insights into tumor biology without the use of radioactive tracers, leveraging existing MRI infrastructure. The company is focused on finalizing trial design and obtaining necessary approvals to commence the study.

Written by 6ix AI from the company’s filing. How 6ix writes summaries